Cytopathology in Focus: Integrating cytology samples into molecular testing of tumors

Create PDF

1. Aisner DL, Rumery MD, Merrick DT, et al. Do more with less: tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the University of  Colorado experience. Arch Pathol Lab Med. 2016;140(11):1206–1220.
2. Tian SK, Killian JK, Rekhtman N, et al. Optimizing workflows and processing of cytologic samples for comprehensive analysis by next-generation sequencing: Memorial Sloan Kettering Cancer Center experience. Arch Pathol Lab Med. 2016;140(11):1200–1205.
3. Saqi A. The state of cell blocks and ancillary testing: past, present, and future. Arch Pathol Lab Med. 2016;140(12):1318–1322.
4. Zhang M, Lin O. Molecular testing of thyroid nodules: a review of current available tests for fine-needle aspiration specimens. Arch Pathol Lab Med. 2016;140(12):1338–1344.
5. Zhou F, Moreira AL. Lung carcinoma predictive biomarker testing by immunoperoxidase stains in cytology and small biopsy specimens: advantages and limitations. Arch Pathol Lab Med. 2016;140(12):1331–1337.
6. Savic S, Bubendorf L. Common fluorescence in situ hybridization applications in cytology. Arch Pathol Lab Med. 2016;140(12):1323–1330.
7. Roy-Chowdhuri S, Stewart J. Preanalytic variables in cytology: lessons learned from next-generation sequencing—the MD Anderson experience. Arch Pathol Lab Med. 2016;140(11):1191–1199.

Dr. Sundling is a junior member of the CAP Cytopathology Committee and a pathology resident at the University of Wisconsin, Madison.